Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107686144 | 10768614 | 4 | F | 20150126 | 20160705 | 20150206 | 20160715 | EXP | JP-ROCHE-1534077 | ROCHE | DOI Y, INOUE Y, DOI Y, ARISATO T, ET AL. A CASE OF HAEMODIALYSIS PATIENT WHO EXPERIENCED DISTURBED CONSCIOUSNESS INDUCED BY CEFTRIAXONE THERAPY.. PROCEEDINGS OF THE 61ST ANNUAL MEETING OF THE JAPANESE SOCIETY FOR DIALYSIS THERAPY; 10-12 JUN 2016, OSAKA-CITY, OSAKA; MAY 2016. 49(S1)926. 2016 MAY;49(S1):926-. | 72.93 | YR | M | Y | 59.00000 | KG | 20160715 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107686144 | 10768614 | 1 | PS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | U | 63239 | 3 | G | QD | |||||||
| 107686144 | 10768614 | 2 | SS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | U | 63239 | 2 | G | BID | |||||||
| 107686144 | 10768614 | 3 | SS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | U | 63239 | 2 | G | QD | |||||||
| 107686144 | 10768614 | 4 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 107686144 | 10768614 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 7.5 | MG | QD | ||||||||
| 107686144 | 10768614 | 6 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 107686144 | 10768614 | 7 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 107686144 | 10768614 | 8 | C | PLETAAL | CILOSTAZOL | 1 | Oral | 0 | 100 | MG | BID | ||||||||
| 107686144 | 10768614 | 9 | C | FOSRENOL | LANTHANUM CARBONATE | 1 | Oral | 0 | 250 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107686144 | 10768614 | 1 | Pneumonia bacterial |
| 107686144 | 10768614 | 2 | Pneumonia bacterial |
| 107686144 | 10768614 | 3 | Pneumonia bacterial |
| 107686144 | 10768614 | 4 | Hypertension |
| 107686144 | 10768614 | 5 | Hyperlipidaemia |
| 107686144 | 10768614 | 6 | Myocardial infarction |
| 107686144 | 10768614 | 7 | Gastric ulcer |
| 107686144 | 10768614 | 8 | Cerebral infarction |
| 107686144 | 10768614 | 9 | Hyperphosphataemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107686144 | 10768614 | HO |
| 107686144 | 10768614 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107686144 | 10768614 | Altered state of consciousness | |
| 107686144 | 10768614 | Chest discomfort | |
| 107686144 | 10768614 | Delirium | |
| 107686144 | 10768614 | Encephalopathy | |
| 107686144 | 10768614 | Myoclonus | |
| 107686144 | 10768614 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107686144 | 10768614 | 1 | 20150119 | 20150119 | 0 | |
| 107686144 | 10768614 | 2 | 20150120 | 20150125 | 0 | |
| 107686144 | 10768614 | 3 | 20150126 | 20150128 | 0 |